+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience



Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience



Digestive and Liver Disease 2019



The transitional process of young patients affected by inflammatory bowel disease from pediatric to adult care is a crucial step. Our study aimed to investigate the 1-year success outcome of this transitional process. From 2013 to 2018, we evaluated the transitional process of patients with Crohn's disease or ulcerative colitis. For each patient, the following parameters 12 months before and 12 months after the transition were evaluated: Body Mass Index, disease activity and smoker status, number of outpatient visits and the pharmacological therapy, the number of disease exacerbations, hospitalizations and surgical interventions. We enrolled 106 patients with IBD. No statistically significant difference was found between patients' Body Mass Index before and after transition. There was a significant reduction in the number of exacerbations and hospitalizations in the 12 months post-transition (pre-transition exacerbations: 0.74 ± 0.79, post-transition exacerbations: 0.35 ± 0.57, p < 0.001; pre-transition hospitalizations: 0.28 ± 0.44, post-transition hospitalizations: 0.1 ± 0.3, p < 0.001). In contrast, there was no significant difference in the number of outpatient visits (3.40 ± 1.4 vs 3.25 ± 1.2; p = ns) and of patients undergoing surgery (0.9% vs 1.8%, p = ns). The parameters used as success indicators of the transition program confirm the achievement of continuity of care from Pediatrics to adult Gastroenterology, in a critical phase of the natural history of IBD patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446961

Download citation: RISBibTeXText

PMID: 30704905

DOI: 10.1016/j.dld.2018.11.034


Related references

Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?. Intestinal Research 2018, 2018

Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key?. Pediatric Gastroenterology, Hepatology & Nutrition 22(1): 28-40, 2019

Barriers and facilitators to successful transition from pediatric to adult inflammatory bowel disease care from the perspectives of providers. Inflammatory Bowel Diseases 20(11): 2083-2091, 2015

Pediatric inflammatory bowel disease in Greece: 30-years experience of a single center. Annals of Gastroenterology 28(1): 81-86, 2015

The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry. Journal of Crohn's and Colitis 8(8): 763-769, 2015

Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease. Inflammatory Bowel Diseases 17(10): 2184-2191, 2012

Transition of Adolescents With Inflammatory Bowel Disease From Pediatric to Adult Care: A Survey of Adult Gastroenterologists. Yearbook of Pediatrics 2011: 178-180, 2011

Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. Yearbook of Pediatrics 2010: 139-141, 2010

Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. Journal of Pediatric Gastroenterology and Nutrition 48(1): 61-65, 2009

Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition 34(3): 245-248, 2002

Progress in the treatment and outcome of pediatric inflammatory bowel disease patients. Expert Review of Clinical Immunology 12(12): 1337-1345, 2016

Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 24(12): 2527-2542, 2018

The Transition From Pediatric to Adult Inflammatory Bowel Disease Care. Gastroenterology and Hepatology 12(6): 403-406, 2016

Mesalamine in pediatric inflammatory bowel disease: a 10-year experience. Inflammatory Bowel Diseases 2(4): 229-235, 1996

Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scandinavian Journal of Gastroenterology 35(12): 1272-1277, 2001